NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 77 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,500 | +37.5% | 75,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $38,175 | -29.3% | 75,000 | -10.5% | 0.00% | 0.0% |
| Q3 2022 | $54,000 | -46.5% | 83,800 | +55.8% | 0.00% | -50.0% |
| Q1 2022 | $101,000 | -74.6% | 53,800 | +53.7% | 0.00% | -77.8% |
| Q1 2020 | $398,000 | -73.1% | 35,000 | -70.8% | 0.01% | -55.0% |
| Q4 2019 | $1,478,000 | +298.4% | 120,000 | -7.7% | 0.02% | +300.0% |
| Q3 2019 | $371,000 | – | 130,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |